Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in Green Monkey Kidney cells

Antiviral Research

Volumn 76, Issue 3, 2007, Pages 252-262

  Ammendolia, Maria Grazia ^a   Marchetti, Magda ^a   Superti, Fabiana ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

GMK cells; HSV 1; Lactoferrin; Viral entry; Viral spreading

Indexed keywords

LACTOFERRIN; VIRUS PROTEIN;

ADSORPTION; ANIMAL CELL; ARTICLE; CELL SPREADING; DRUG INHIBITION; HERPES SIMPLEX VIRUS 1; INFECTION PREVENTION; KIDNEY CELL; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; VIRUS INFECTION; VIRUS INFECTIVITY;

ANIMALS; ANTIVIRAL AGENTS; CATTLE; CELL LINE; CERCOPITHECUS AETHIOPS; HERPESVIRUS 1, HUMAN; LACTOFERRIN; PLAQUE ASSAY; PROTEIN BINDING; VIRAL PROTEINS; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

BOVINAE; CERCOPITHECUS AETHIOPS; CYTOMEGALOVIRUS; FUNGI; HUMAN HERPESVIRUS 1;

EID: 35348945790     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2007.07.005     Document Type: Article

References (63)

1. Ammendolia M.G., Pietrantoni A., Tinari A., Valenti P., and Superti F. Bovine lactoferrin inhibits echovirus endocytic pathway by interacting with viral structural polypeptides. Antiviral Res. 73 (2007) 151-160
2. Andersen J.H., Osbakk S.A., Vorland L.H., Traavik T., and Gutteberg T.J. Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts. Antiviral Res. 51 (2001) 141-149
3. Andersen J.H., Jenssen H., and Gutteberg T.J. Lactoferrin and lactoferricin inhibit herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir. Antiviral Res. 58 (2003) 209-215
4. Andersen J.H., Jenssen H., Sandvik K., and Gutteberg T.J. The anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface. J. Med. Virol. 74 (2004) 262-271
5. Arnold D., Di Biase A.M., Marchetti M., Pietrantoni A., Valenti P., Seganti L., and Superti F. Antiadenovirus activity of milk proteins: lactoferrin prevents viral infection. Antiviral Res. 53 (2002) 153-158
6. Beljaars L., van der Strate B.W., Bakker H.I., Reker-Smit C., van Loenen-Weemaes A.M., Wiegmans F.C., Harmsen M.C., Molema G., and Meijer D.K. Inhibition of cytomegalovirus infection by lactoferrin in vitro and in vivo. Antiviral Res. 63 (2004) 197-208
7. Berkhout B., van Wamel J.L., Beljaars L., Meijer D.K., Visser S., and Floris R. Characterization of the anti-HIV effects of native lactoferrin and other milk proteins and protein-derived peptides. Antiviral Res. 55 (2002) 341-355
8. Berkhout B., Floris R., Recio I., and Visser S. The antiviral activity of the milk protein lactoferrin against the human immunodeficiency virus type 1. Biometals 17 (2004) 291-294
9. Coen D.M. Acyclovir-resistant, pathogenic herpesviruses. Trends Microbiol. 2 (1994) 481-485
10. Dechecchi M.C., Melotti P., Bonizzato A., Santacatterina M., Chilosi M., and Cabrini G. Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J. Virol. 75 (2001) 8772-8780
11. Desai P., and Person S. Incorporation of the green fluorescent protein into the herpes simplex virus type 1 capsid. J. Virol. 72 (1998) 7563-7568
12. Di Biase A.M., Pietrantoni A., Tinari A., Siciliano R., Valenti P., Antonini G., Seganti L., and Superti F. Heparin-interacting sites of bovine lactoferrin are involved in anti-adenovirus activity. J. Med. Virol. 69 (2003) 495-502
13. Drobni P., Näslund J., and Evander M. Lactoferrin inhibits human papillomavirus binding and uptake in vitro. Antiviral Res. 64 (2004) 63-68
14. Elliott G., Mouzakitis G., and O'Hare P. VP16 interacts via its activation domain with VP22, a tegument protein of herpes simplex virus, and is relocated to a novel macromolecular assembly in coexpressing cells. J. Virol. 69 (1995) 7932-7941
15. Fujihara T., and Hayashi K. Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea. Arch. Virol. 140 (1995) 1469-1472
16. Giroglou T., Florin L., Schäfer F., Streeck R.E., and Sapp M. Human papillomavirus infection requires cell surface heparan sulfate. J. Virol. 75 (2001) 1565-1570
17. Groves M.L. The isolation of a red protein from milk. J. Am. Chem. Soc. 82 (1960) 3345-3350
18. Hara K., Ikeda M., Saito S., Matsumoto S., Numata K., Kato N., Tanaka K., and Sekihara H. Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes. Hepatol. Res. 24 (2002) 228-235
19. Harmsen M.C., Swart P.J., de Béthune M.P., Pauwels R., De Clercq E., Thé T.H., and Meijer D.K.F. Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J. Infect. Dis. 172 (1995) 380-388
20. Hasegawa K., Motsuchi W., Tanaka S., and Dosako S. Inhibition with lactoferrin of in vitro infection with human herpes virus. Jpn. J. Med. Sci. Biol. 47 (1994) 73-85
21. Holland T.C., Homa F.L., Marlin S.D., Levine M., and Glorioso J. Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteins. J. Virol. 52 (1984) 566-574
22. Ikeda M., Sugiyama K., Tanaka T., Tanaka K., Sekihara H., Shimotohno K., and Kato N. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes. Biochem. Biophys. Res. Commun. 245 (1998) 549-553
23. Ikeda M., Nozaki A., Sugiyama K., Tanaka T., Naganuma A., Tanaka K., Sekihara H., Shimotohno K., Saito M., and Kato N. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells. Virus Res. 66 (2000) 51-63
24. Jenssen H. Anti herpes simplex virus activity of lactoferrin/lactoferricin-an example of antiviral activity of antimicrobial protein/peptide. Cell. Mol. Life Sci. 62 (2005) 3002-3013
25. Jenssen H., Andersen J.H., Uhlin-Hansen L., Gutteberg T.J., and Rekdal ∅. Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate. Antiviral Res. 61 (2004) 101-109
26. Ji Z.S., and Mahley R.W. Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG. Arterioscler. Thromb. 14 (1994) 2025-2031
27. Kolokotronis A., and Doumas S. Herpes simplex virus infection, with particular reference to the progression and complications of primary herpetic gingivostomatitis. Clin. Microbiol. Infect. 12 (2006) 202-211
28. Laemmli U.K. Cleavage of structural prroteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
29. Levay P.F., and Viljoen M. Lactoferrin: a general review. Haematologica 80 (1995) 252-267
30. Lin T.Y., Chu C., and Chiu C.H. Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro. J. Infect. Dis. 186 (2002) 1161-1164
31. Lindahl U., Lidholt K., Spillmann D., and Kjéllen L. More to "heparin" than anticoagulation. Thromb. Res. 75 (1994) 1-32
32. Mann D.M., Romm E., and Migliorini M. Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin. J. Biol. Chem. 269 (1994) 23661-23667
33. Marchetti M., and Superti F. Antiviral activity of lactoferrin. In: Pandalai S.G. (Ed). Recent Developments in Antiviral Research (2001), Transworld Research Network, Trivandrum, India 193-203
34. Marchetti M., Longhi C., Conte M.P., Pisani S., Valenti P., and Seganti L. Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells. Antiviral Res. 29 (1996) 221-231
35. Marchetti M., Pisani S., Antonini G., Valenti P., Seganti L., and Orsi N. Metal complexes of bovine lactoferrin inhibit in vitro replication of herpes simplex virus type 1 and 2. Biometals 11 (1998) 89-94
36. Marchetti M., Superti F., Ammendolia M.G., Rossi P., Valenti P., and Seganti L. Inhibition of poliovirus type 1 infection by iron-, manganese- and zinc-saturated lactoferrin. Med. Microbiol. Immunol. 187 (1999) 199-204
37. Marchetti M., Trybala E., Superti F., Johansson M., and Bergstöm T. Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans. Virology 318 (2004) 405-413
38. McCann K.B., Lee A., Wan J., Roginski H., and Coventry M.J. The effect of bovine lactoferrin and lactoferricin B on the ability of feline calicivirus (a norovirus surrogate) and poliovirus to infect cell cultures. J. Appl. Microbiol. 95 (2003) 1026-1033
39. Metz-Boutigue M.H., Jollès J., Mazurier J., Schoentgen F., Legrand D., Spik G., Montreuil J., and Jollès P. Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins. Eur. J. Biochem. 145 (1984) 659-676
40. Murphy M.E., Kariwa H., Mizutani T., Yoshimatsu K., Arikawa J., and Takashima I. In vitro antiviral activity of lactoferrin and ribavirin upon hantavirus. Arch. Virol. 145 (2000) 1571-1582
41. Pietrantoni A., Di Biase A.M., Tinari A., Marchetti M., Valenti P., Seganti L., and Superti F. Bovine lactoferrin inhibits adenovirus infection by interacting with viral structural polypeptides. Antimicrob. Agents Chemother. 47 (2003) 2688-2691
42. Pietrantoni A., Ammendolia M.G., Tinari A., Siciliano R., Valenti P., and Superti F. Bovine lactoferrin peptidic fragments involved in inhibition of Echovirus 6 in vitro infection. Antiviral Res. 69 (2006) 98-106
43. Pomeranz L.E., and Blaho J.A. Modified VP22 localizes to the cell nucleus during synchronized herpes simplex virus type 1 infection. J. Virol. 73 (1999) 6769-6781
44. Puddu P., Borghi P., Gessani S., Valenti P., Belardelli F., and Seganti L. Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection. Int. J. Biochem. Cell Biol. 30 (1998) 1055-1062
45. Remeijer L., Osterhaus A., and Verjans G. Human herpes simplex virus keratitis: the pathogenesis revisited. Ocul. Immunol. Inflamm. 12 (2004) 255-285
46. Sano H., Nagai K., Tsutsumi H., and Kuroki Y. Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection. Eur. J. Immunol. 33 (2003) 2894-2902
47. Seganti L., Di Biase A.M., Marchetti M., Pietrantoni A., Tinari A., and Superti F. Antiviral activity of lactoferrin towards naked viruses. Biometals 17 (2004) 295-299
48. Shimazaki K., Tazume T., Uji K., Tanaka M., Kumura H., Mikawa K., and Shimo-Oka T. Properties of a heparin-binding peptide derived from bovine lactoferrin. J. Dairy Sci. 81 (1998) 2841-2849
49. Spruance S.L., Overall Jr. J.C., Kern E.R., Krueger G.G., Pliam V., and Miller W. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N. Engl. J. Med. 297 (1977) 69-75
50. Superti F., Ammendolia M.G., Valenti P., and Seganti L. Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29. Med. Microbiol. Immunol. 186 (1997) 83-91
51. Superti F., Siciliano R., Rega B., Giansanti F., Valenti P., and Antonini G. Involvement of bovine lactoferrin metal saturation, sialic acid and protein fragments in the inhibition of rotavirus infection. Biochim. Biophys. Acta 1528 (2001) 107-115
52. Swart P.J., Kuipers M.E., Smit C., Pauwels R., de Béthune M.P., De Clercq E., Meijer D.K.F., and Huisman J.G. Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro. AIDS Res. Hum. Retroviruses 12 (1996) 769-775
53. Tinari A., Pietrantoni A., Ammendolia M.G., Valenti P., and Superti F. Inhibitory activity of bovine lactoferrin against echovirus induced programmed cell death in vitro. Int. J. Antimicrob. Agents 25 (2005) 433-438
54. Trybala E., Liljeqvist J.A., Svennerholm B., and Bergström T. Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate. J. Virol. 74 (2000) 9106-9114
55. Valenti P., and Antonini G. Lactoferrin: an important host defence against microbial and viral attack. Cell Mol. Life Sci. 62 (2005) 2576-2587
56. Valenti P., Marchetti M., Superti F., Ammendolia M.G., Puddu P., Gessani S., Borghi P., Belardelli F., Antonimi G., and Seganti L. Antiviral activity of lactoferrin. Adv. Exp. Med. Biol. 443 (1998) 199-203
57. van der Strate B.W., Beljaars L., Molema G., Harmsen M.C., and Meijer D.K. Antiviral activities of lactoferrin. Antiviral Res. 52 (2001) 225-239
58. Vorland L.H. Lactoferrin: a multifunctional glycoprotein. APMIS 107 (1999) 971-981
59. Weinheimer S.P., Boyd B.A., Durham S.K., Resnick J.L., and O'Boyle D.R. Deletion of the VP16 open reading frame of herpes simplex virus type 1. J. Virol. 66 (1992) 258-269
60. Whitley R.J., and Roizman B. Herpes simplex virus infections. Lancet 357 (2001) 1513-1518
61. Whitley R.J., Soong S.J., Hirsch M.S., Karchmer A.W., Dolin R., Galasso G., Dunnick J.K., and Alford C.A. Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N. Engl. J. Med. 304 (1981) 313-318
62. Wu H.F., Monroe D.M., and Church F.C. Characterization of the glycosaminoglycan-binding region of lactoferrin. Arch. Biochem. Biophys. 317 (1995) 85-92
63. WuDunn D., and Spear P.G. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 69 (1989) 2233-2239